BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34844535)

  • 1. Oligonucleotides Carrying Nucleoside Antimetabolites as Potential Prodrugs.
    Fàbrega C; Clua A; Eritja R; Aviñó A
    Curr Med Chem; 2023; 30(11):1304-1319. PubMed ID: 34844535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery to PEPT1-overexpressing cells: acidic, basic, and secondary floxuridine amino acid ester prodrugs.
    Landowski CP; Vig BS; Song X; Amidon GL
    Mol Cancer Ther; 2005 Apr; 4(4):659-67. PubMed ID: 15827340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleosides with Transposed Base or 4'-Hydroxymethyl Moieties and Their Corresponding Oligonucleotides.
    Toti K; Renders M; Groaz E; Herdewijn P; Van Calenbergh S
    Chem Rev; 2015 Dec; 115(24):13484-525. PubMed ID: 26655745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel anticancer polymeric conjugates of activated nucleoside analogues.
    Senanayake TH; Warren G; Vinogradov SV
    Bioconjug Chem; 2011 Oct; 22(10):1983-93. PubMed ID: 21863885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel developments in the use of antimetabolites.
    Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):358-74. PubMed ID: 24940694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years.
    Sinokrot H; Smerat T; Najjar A; Karaman R
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29035325
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antisense oligonucleotides with antitumor activity].
    Otvös L; Sági G
    Magy Onkol; 2004; 48(3):221-7. PubMed ID: 15520872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntheses of prodrug-type 2'-O-methyldithiomethyl oligonucleotides modified at natural four nucleoside residues and their conversions into natural 2'-hydroxy oligonucleotides under reducing condition.
    Hayashi J; Ochi Y; Morita Y; Soubou K; Ohtomo Y; Nishigaki M; Tochiyama Y; Nakagawa O; Wada SI; Urata H
    Bioorg Med Chem; 2018 Dec; 26(22):5838-5844. PubMed ID: 30420326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleoside diphosphate prodrugs.
    Meier C; Jessen HJ; Balzarini J
    Nucleic Acids Symp Ser (Oxf); 2008; (52):83-4. PubMed ID: 18776264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleoside ester prodrug substrate specificity of liver carboxylesterase.
    Landowski CP; Lorenzi PL; Song X; Amidon GL
    J Pharmacol Exp Ther; 2006 Feb; 316(2):572-80. PubMed ID: 16223870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prodrug approaches of nucleotides and oligonucleotides.
    Poijärvi-Virta P
    Curr Med Chem; 2006; 13(28):3441-65. PubMed ID: 17168716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino Acid Ester Prodrugs of Nucleoside and Nucleotide Antivirals.
    Krecmerova M
    Mini Rev Med Chem; 2017; 17(10):818-833. PubMed ID: 28215138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodrugs of Nucleoside Triphosphates as a Sound and Challenging Approach: A Pioneering Work That Opens a New Era in the Direct Intracellular Delivery of Nucleoside Triphosphates.
    Camarasa MJ
    ChemMedChem; 2018 Sep; 13(18):1885-1889. PubMed ID: 30152096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-Engineering RNA Molecules into Therapeutic Agents.
    Egli M; Manoharan M
    Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies.
    Maksimenko A; Caron J; Mougin J; Desmaële D; Couvreur P
    Int J Pharm; 2015 Mar; 482(1-2):38-46. PubMed ID: 25448549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocatalytic approaches applied to the synthesis of nucleoside prodrugs.
    Iglesias LE; Lewkowicz ES; Medici R; Bianchi P; Iribarren AM
    Biotechnol Adv; 2015; 33(5):412-34. PubMed ID: 25795057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleosides and nucleotides. 131. Synthesis and properties of oligonucleotides containing 5-formyl-2'-deoxyuridine.
    Ono A; Okamoto T; Inada M; Nara H; Matsuda A
    Chem Pharm Bull (Tokyo); 1994 Nov; 42(11):2231-7. PubMed ID: 7859326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates.
    Thornton PJ; Kadri H; Miccoli A; Mehellou Y
    J Med Chem; 2016 Dec; 59(23):10400-10410. PubMed ID: 27559756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Freeze-drying of squalenoylated nucleoside analogue nanoparticles.
    Bildstein L; Hillaireau H; Desmaële D; Lepêtre-Mouelhi S; Dubernet C; Couvreur P
    Int J Pharm; 2009 Nov; 381(2):140-5. PubMed ID: 19782881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for the Synthesis of Fluorinated Nucleosides, Nucleotides and Oligonucleotides.
    Shet H; Sahu R; Sanghvi YS; Kapdi AR
    Chem Rec; 2022 Sep; 22(9):e202200066. PubMed ID: 35638251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.